A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg

Clinical trial NCT00313170 · COMPLETED

Trial details

NCT number: NCT00313170
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer Metastatic Breast Cancer

Start date: 2006-05-30
Primary completion: 2008-06-13
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.